Intact Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.4M | Buy |
679,300
+63,800
| +10% | +$1.67M | 0.46% | 54 |
|
|
2026
Q1 | $17.3M | Sell |
615,500
-3,100
| -0.5% | -$82.5K | 0.49% | 57 |
|
|
2025
Q4 | $15.4M | Sell |
618,600
-53,100
| -8% | -$1.34M | 0.44% | 56 |
|
|
2025
Q3 | $17.1M | Buy |
671,700
+3,100
| +0.5% | +$76.5K | 0.52% | 51 |
|
|
2025
Q2 | $16.2M | Sell |
668,600
-75,800
| -10% | -$1.77M | 0.55% | 48 |
|
|
2025
Q1 | $18.9M | Hold |
744,400
| – | – | 0.65% | 42 |
|
|
2024
Q4 | $19.7M | Buy |
744,400
+306,900
| +70% | +$8.32M | 0.69% | 35 |
|
|
2024
Q3 | $12.7M | Buy |
437,500
+14,300
| +3% | +$417K | 0.42% | 61 |
|
|
2024
Q2 | $11.8M | Buy |
423,200
+38,200
| +10% | +$1.05M | 0.44% | 50 |
|
|
2024
Q1 | $10.7M | Sell |
385,000
-53,800
| -12% | -$1.49M | 0.42% | 55 |
|
|
2023
Q4 | $12.6M | Buy |
438,800
+103,600
| +31% | +$3.13M | 0.51% | 41 |
|
|
2023
Q3 | $11.1M | Sell |
335,200
-25,700
| -7% | -$909K | 0.48% | 45 |
|
|
2023
Q2 | $13.2M | Sell |
360,900
-13,400
| -4% | -$522K | 0.54% | 45 |
|
|
2023
Q1 | $15.3M | Buy |
374,300
+42,600
| +13% | +$1.84M | 0.63% | 38 |
|
|
2022
Q4 | $17M | Sell |
331,700
-53,500
| -14% | -$2.56M | 0.74% | 32 |
|
|
2022
Q3 | $16.9M | Buy |
385,200
+42,800
| +13% | +$2.08M | 0.56% | 36 |
|
|
2022
Q2 | $18M | Sell |
342,400
-16,000
| -4% | -$815K | 0.56% | 38 |
|
|
2022
Q1 | $18.6M | Buy |
358,400
+45,400
| +15% | +$2.36M | 0.47% | 47 |
|
|
2021
Q4 | $18.5M | Sell |
313,000
-4,200
| -1% | -$208K | 0.47% | 48 |
|
|
2021
Q3 | $13.6M | Sell |
317,200
-41,200
| -11% | -$1.83M | 0.38% | 54 |
|
|
2021
Q2 | $14M | Sell |
358,400
-3,600
| -1% | -$140K | 0.4% | 56 |
|
|
2021
Q1 | $13.1M | Sell |
362,000
-26,000
| -7% | -$923K | 0.4% | 55 |
|
|
2020
Q4 | $14.3M | Sell |
388,000
-20,952
| -5% | -$769K | 0.46% | 46 |
|
|
2020
Q3 | $14.2M | Sell |
408,952
-79,050
| -16% | -$2.77M | 0.49% | 42 |
|
|
2020
Q2 | $15.1M | Buy |
488,002
+36,995
| +8% | +$1.26M | 0.57% | 36 |
|
|
2020
Q1 | $14M | Buy |
451,007
+66,613
| +17% | +$2.27M | 0.61% | 37 |
|
|
2019
Q4 | $14.3M | Buy |
384,394
+26,034
| +7% | +$927K | 0.48% | 43 |
|
|
2019
Q3 | $12.2M | Buy |
358,360
+38,998
| +12% | +$1.42M | 0.43% | 47 |
|
|
2019
Q2 | $13.1M | Buy |
319,362
+3,478
| +1% | +$138K | 0.47% | 46 |
|
|
2019
Q1 | $12.7M | Buy |
315,884
+4,005
| +1% | +$160K | 0.45% | 46 |
|
|
2018
Q4 | $12.9M | Hold |
311,879
| – | – | 0.52% | 40 |
|
|
2018
Q3 | $13M | Sell |
311,879
-118,891
| -28% | -$4.58M | 0.46% | 45 |
|
|
2018
Q2 | $14.8M | Sell |
430,770
-15,072
| -3% | -$515K | 0.53% | 38 |
|
|
2018
Q1 | $15M | Sell |
445,842
-145,347
| -25% | -$5M | 0.58% | 36 |
|
|
2017
Q4 | $20.3M | Sell |
591,189
-6,745
| -1% | -$230K | 0.82% | 33 |
|
|
2017
Q3 | $20.2M | Sell |
597,934
-17,707
| -3% | -$569K | 0.88% | 31 |
|
|
2017
Q2 | $19.6M | Sell |
615,641
-78,102
| -11% | -$2.46M | 0.87% | 29 |
|
|
2017
Q1 | $22.5M | Sell |
693,743
-140,393
| -17% | -$4.43M | 0.91% | 30 |
|
|
2016
Q4 | $25.7M | Buy |
834,136
+34,361
| +4% | +$1.05M | 0.95% | 28 |
|
|
2016
Q3 | $25.7M | Buy |
799,775
+19,710
| +3% | +$659K | 0.97% | 31 |
|
|
2016
Q2 | $26.1M | Sell |
780,065
-97,917
| -11% | -$3.13M | 1.06% | 26 |
|
|
2016
Q1 | $24.7M | Buy |
877,982
+229,456
| +35% | +$6.55M | 1.01% | 27 |
|
|
2015
Q4 | $19.9M | Buy |
648,526
+71,250
| +12% | +$2.24M | 0.89% | 32 |
|
|
2015
Q3 | $17.2M | Sell |
577,276
-2,213
| -0.4% | -$71K | 0.77% | 37 |
|
|
2015
Q2 | $18.4M | Sell |
579,489
-52,173
| -8% | -$1.7M | 0.76% | 40 |
|
|
2015
Q1 | $20.9M | Sell |
631,662
-118,154
| -16% | -$3.76M | 0.84% | 37 |
|
|
2014
Q4 | $22.2M | Buy |
749,816
+301,866
| +67% | +$8.66M | 0.88% | 32 |
|
|
2014
Q3 | $12.6M | Buy |
447,950
+197,836
| +79% | +$5.55M | 0.52% | 38 |
|
|
2014
Q2 | $7.04M | Buy |
250,114
+28,395
| +13% | +$809K | 0.29% | 50 |
|
|
2014
Q1 | $6.76M | Buy |
221,719
+161,430
| +268% | +$4.81M | 0.3% | 46 |
|
|
2013
Q4 | $1.75M | Hold |
60,289
| – | – | 0.08% | 73 |
|
|
2013
Q3 | $1.64M | Buy |
60,289
+37,312
| +162% | +$1.02M | 0.09% | 68 |
|
|
2013
Q2 | $611K | Buy |
+22,977
| New | +$635K | 0.03% | 75 |
|
Other funds holding PFE
Intact Investment Management's PFE Position: Q2 2026 in Review
Intact Investment Management increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $1.67M and bringing the position to 679,300 shares worth $16.4M. The position accounts for 0.46% of the portfolio, ranked #54.
Intact Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.1M in Q2 2016. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Intact Investment Management held 679,300 shares of Pfizer worth $16.4M as of Q2 2026.
- Intact Investment Management bought 63,800 Pfizer shares in Q2 2026, an estimated $1.67M.
- Pfizer made up 0.46% of Intact Investment Management's portfolio in Q2 2026, its #54 holding.
- Intact Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Intact Investment Management's Pfizer position peaked at $26.1M in Q2 2016.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.